Alexandra Williams is a recognized healthcare strategy leader with over 15 years of 340B Drug Pricing Program expertise across provider, consulting, and pharmaceutical sectors. Alexandra serves as Director, Strategy & Innovation, as part of AbbVie’s 340B Center of Excellence, leading the 340B commercial strategy for the organization. Alexandra previously led 340B strategy at Bristol Myers Squibb, OSU Wexner Medical Center, and Apexus (HRSA’s 340B Prime Vendor Program), and served as a 340B auditor on behalf of HRSA. She is a national 340B expert and sought-after conference speaker and educator. Alexandra obtained her Master of Public Health degree from The Ohio State University and her Bachelor of Arts Biology & Health Sciences degree from Guilford College.